Stanley Druckenmiller's position in Verona Pharma Plc is currently worth $94.6 Million. That's 2.75% of their equity portfolio (10th largest holding). The investor owns 1.18% of the outstanding Verona Pharma Plc stock. The stake costed the investor $31.3 Million, netting the investor a gain of 202% so far.